SHAHINA JAFRY: Open Payments
NPI 1053383737 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,601 in 230 payments from 17 companies in 2025. Trend: 2023 $15,001 · 2024 $3,710 · 2025 $16,601
Food & beverage: $4,814Speaker / faculty: $4,370Travel & lodging: $3,884Consulting: $3,450Education: $83
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 59 | $12,885 |
| Vanda Pharmaceuticals Inc. | 19 | $593 |
| ABBVIE INC. | 24 | $454 |
| Alkermes, Inc. | 18 | $389 |
| Axsome Therapeutics, Inc. | 11 | $319 |
| HARMONY BIOSCIENCES LLC | 9 | $270 |
| Teva Pharmaceuticals USA, Inc. | 17 | $253 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $251 |
| Lundbeck LLC | 13 | $247 |
| Neurocrine BioSciences, Inc. | 13 | $242 |
Products named: COBENFY, VRAYLAR, ARISTADA, HETLIOZ, Auvelity, REXULTI, FANAPT, CAPLYTA.
Industry payments across IL — which companies pay providers there.
